A Study of Baricitinib (LY3009104) in Healthy Chinese Participants
Clinical trial NCT02758613 · COMPLETED
Trial details
- NCT number
- NCT02758613
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2016-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.